Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cancer & Stem Cells

Enal Razvi's Biography

Enal Razvi, Managing Director, Select Biosciences Inc

Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world.

Dr. Razvi can be reached at:

Enal Razvi Image

Market Trends in the use of Stem Cells for Cancer Therapeutics: From BMTs to Cord Blood

Tuesday, 22 January 2013 at 14:45

Add to Calendar ▼2013-01-22 11:15:002013-01-22 12:15:00Europe/LondonCTCs: Analysis of Market Trends and Clinical

Select Biosciences industry coverage of the stem cells field covers many market segments. In this presentation, we focus upon the use of various classes of stem cells for hematological and solid tumor therapies. Presented here are the use of bone marrow, peripheral blood, and cord blood and the associated market trends. Also, we present the current research efforts in the hematological cancer space plus an analysis of the clinical trials pipeline. Taken together, this presentation will provide a market assessment of the utility of stem cells in cancer therapeutics.

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCancer and Stem